Tigilanol tiglate is under clinical development by QBiotics Group and currently in Phase I for Breast Cancer. According to GlobalData, Phase I drugs for Breast Cancer have a 72% phase transition ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
Purpose: Nevoid Basal Cell Carcinoma Syndrome (NBCCS ... Hyperaeration of the frontal sinuses was observed in 18% of the NBCCS group only. CT studies of the cerebrum were obtained in 42 and ...
Methods: An experimental kidney transplant model was conducted. Rats were divided into three groups: an intervention free basal group from which physiological data was collected; a control group (CT), ...
At least 22 Palestinians were killed in Israeli airstrikes across the Gaza Strip on Wednesday Palestinian sources said Mahmoud Basal spokesperson f ...